Detty Siti Nurdiati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Detty Siti Nurdiati has a total of 144 co-authors. Here are the top co-authors by number of shared publications:
- Hamam Hadi
Alma Ata Graduate School of Public Health, The University of Alma Ata, Yogyakarta 55183, Indonesia
5 shared publications - Joel Gittelsohn
Johns Hopkins University
3 shared publications - Prenali Dwisthi Sattwika
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Cardiovascular Clinical Research Facility, University of Oxford , Level 1, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford
3 shared publications - Siti Nurunniyah
Department of Midwifery, Faculty of Health Sciences, The University of Alma Ata, Yogyakarta 55183, Indonesia
3 shared publications - Aulia Ichlasul Rezza
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
2 shared publications - Dean Batrisha
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
2 shared publications
Latest Publications
- Open Access
- 31 May 2026
- Published by Korean Society for Bone and Mineral Research in Journal of Bone Metabolism
- Vol. 33 (2) , 113-126
Impact of Maternal Vitamin D Levels on Offspring Bone Development: Systematic Review
Background: Maternal vitamin D is essential for fetal calcium homeostasis and skeletal development. The long-term impact of maternal vitamin D status during pregnancy on offspring bone health remains unclear, especially in populations with high sun exposure yet persistent deficiency. This systematic review synthesizes cohort study on the association between maternal serum 25-hydroxy-vitamin D (25[OH]D) levels during pregnancy and bone outcomes in offspring.Methods: A total of 19 cohort studies, comprising 12,835 mother-offspring pairs across diverse geographic regions, were systematically reviewed. Offspring bone health indicators included bone mineral content (BMC), bone mineral density (BMD), bone turnover biomarkers, and fracture risk, assessed using dual energy X-ray absorptiometry (DXA), quantitative ultrasound (QUS), and biochemical markers. Heterogeneity in vitamin D thresholds, measurement timing, and follow-up duration was noted.Results: The findings were heterogeneous and often sex-specific. Some studies reported a positive association between higher maternal 25(OH)D levels and increased BMC/BMD, particularly in male offspring. Others showed no significant association after adjusting for maternal and neonatal confounders. Biomarker analyses generally supported an inverse relationship between maternal vitamin D deficiency and fetal bone turnover markers. However, evidence remains inconclusive regarding the benefits of prenatal vitamin D supplementation on long-term skeletal outcomes.Conclusions: Maternal vitamin D status appears to influence offspring bone development in a complex and multifactorial manner. Effects may be modified by child sex, timing of deficiency during gestation, and genetic factors. Future studies should prioritize standardized measurement protocols and expand cohort representation in under-researched regions, notably Southeast Asia, to inform public health guidelines and targeted interventions.
- 31 May 2026
- Published by Korean Society for Bone and Mineral Research in Journal of Bone Metabolism
- Vol. 33 (2) , 113-126
Open AccessImpact of Maternal Vitamin D Levels on Offspring Bone Development: Systematic Review
Background: Maternal vitamin D is essential for fetal calcium homeostasis and skeletal development. The long-term impact of maternal vitamin D status during pregnancy on offspring bone health remains unclear, especially in populations with high sun exposure yet persistent deficiency. This systematic review synthesizes cohort study on the association between maternal serum 25-hydroxy-vitamin D (25[OH]D) levels during pregnancy and bone outcomes in offspring.Methods: A total of 19 cohort studies, comprising 12,835 mother-offspring pairs across diverse geographic regions, were systematically reviewed. Offspring bone health indicators included bone mineral content (BMC), bone mineral density (BMD), bone turnover biomarkers, and fracture risk, assessed using dual energy X-ray absorptiometry (DXA), quantitative ultrasound (QUS), and biochemical markers. Heterogeneity in vitamin D thresholds, measurement timing, and follow-up duration was noted.Results: The findings were heterogeneous and often sex-specific. Some studies reported a positive association between higher maternal 25(OH)D levels and increased BMC/BMD, particularly in male offspring. Others showed no significant association after adjusting for maternal and neonatal confounders. Biomarker analyses generally supported an inverse relationship between maternal vitamin D deficiency and fetal bone turnover markers. However, evidence remains inconclusive regarding the benefits of prenatal vitamin D supplementation on long-term skeletal outcomes.Conclusions: Maternal vitamin D status appears to influence offspring bone development in a complex and multifactorial manner. Effects may be modified by child sex, timing of deficiency during gestation, and genetic factors. Future studies should prioritize standardized measurement protocols and expand cohort representation in under-researched regions, notably Southeast Asia, to inform public health guidelines and targeted interventions.
- Open Access
- 11 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 538
Clinical Evidence of Wearable-Derived Heart Rate Variability for Detecting Systemic Inflammation: A Systematic Review
Background/Objectives: Wearable devices capable of capturing heart rate variability (HRV) enable continuous assessment of autonomic nervous system function in real-world settings. Because systemic inflammation disrupts autonomic balance through vagal withdrawal and sympathetic activation, HRV has been proposed as a non-invasive digital biomarker of inflammatory activity. Despite the rapid expansion of wearable sensor technologies, the accuracy and consistency for detecting systemic inflammatory states remain unclear. This systematic review aimed to evaluate the clinical relevance of wearable-derived HRV indices in relation to established inflammatory biomarkers. Methods: A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted through April 2025. Due to methodological heterogeneity, findings were synthesized using the Synthesis Without Meta-analysis (SWiM) framework with vote counting, effect-direction plots, and sign tests. Results: Eleven studies involving 2419 participants met the inclusion criteria. Vote counting demonstrated that SDNN showed a predominantly inverse association with CRP, with 83% of comparisons indicating reduced SDNN in the presence of elevated CRP (sign test p = 0.031). In contrast, associations between RMSSD and inflammatory cytokines were heterogeneous and largely non-significant. ECG-based wearable devices yielded more consistent associations than photoplethysmography-based devices, while recording duration and population characteristics contributed to variability across studies. Conclusions: Wearable-derived HRV, particularly SDNN from ECG-based devices, shows a consistent inverse association with CRP, supporting its role as a non-invasive physiological correlate of systemic inflammation. However, heterogeneity and the lack of diagnostic accuracy metrics limit conclusions regarding clinical utility. At present, wearable HRV should be considered an exploratory or adjunctive biomarker, pending validation in standardized longitudinal studies with formal diagnostic performance assessment.
- 11 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 538
Open AccessClinical Evidence of Wearable-Derived Heart Rate Variability for Detecting Systemic Inflammation: A Systematic Review
Background/Objectives: Wearable devices capable of capturing heart rate variability (HRV) enable continuous assessment of autonomic nervous system function in real-world settings. Because systemic inflammation disrupts autonomic balance through vagal withdrawal and sympathetic activation, HRV has been proposed as a non-invasive digital biomarker of inflammatory activity. Despite the rapid expansion of wearable sensor technologies, the accuracy and consistency for detecting systemic inflammatory states remain unclear. This systematic review aimed to evaluate the clinical relevance of wearable-derived HRV indices in relation to established inflammatory biomarkers. Methods: A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted through April 2025. Due to methodological heterogeneity, findings were synthesized using the Synthesis Without Meta-analysis (SWiM) framework with vote counting, effect-direction plots, and sign tests. Results: Eleven studies involving 2419 participants met the inclusion criteria. Vote counting demonstrated that SDNN showed a predominantly inverse association with CRP, with 83% of comparisons indicating reduced SDNN in the presence of elevated CRP (sign test p = 0.031). In contrast, associations between RMSSD and inflammatory cytokines were heterogeneous and largely non-significant. ECG-based wearable devices yielded more consistent associations than photoplethysmography-based devices, while recording duration and population characteristics contributed to variability across studies. Conclusions: Wearable-derived HRV, particularly SDNN from ECG-based devices, shows a consistent inverse association with CRP, supporting its role as a non-invasive physiological correlate of systemic inflammation. However, heterogeneity and the lack of diagnostic accuracy metrics limit conclusions regarding clinical utility. At present, wearable HRV should be considered an exploratory or adjunctive biomarker, pending validation in standardized longitudinal studies with formal diagnostic performance assessment.
- Open Access
- 6 November 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Pregnancy Outcomes in Adult Congenital Heart Disease Patients with Pulmonary Hypertension in Indonesia
Congenital heart disease (CHD) and pulmonary hypertension represent significant risk factors for adverse pregnancy outcomes and are associated with considerable maternal mortality, contributing to approximately 9% of maternal deaths globally. Among cardiovascular diseases complicating pregnancy, CHD is the most prevalent subtype. Here we conducted a comprehensive literature review on maternal and foetal outcomes associated with adult CHD-related pulmonary hypertension, also incorporating data from four pulmonary hypertension centres in Indonesia. Consistent with global epidemiological trends, atrial septal defect emerged as the most frequently observed form of CHD, followed by ventricular septal defect, across the four Indonesian centres. Maternal cardiovascular complications in this context include heart failure, arrhythmias, pulmonary hypertensive crises, thromboembolic events and aortic dissection. These haemodynamic disturbances further elevate the risk of adverse foetal outcomes, such as prematurity, low birth weight, intrauterine growth restriction and foetal demise. Effective and timely management of CHD and pulmonary hypertension – centred on optimising right ventricular function during pregnancy – is critical. Implementation of a comprehensive, multidisciplinary care approach, alongside the expansion of screening programmes for CHD in pregnant populations, is essential to improve maternal and foetal outcomes.
- 6 November 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Open AccessPregnancy Outcomes in Adult Congenital Heart Disease Patients with Pulmonary Hypertension in Indonesia
Congenital heart disease (CHD) and pulmonary hypertension represent significant risk factors for adverse pregnancy outcomes and are associated with considerable maternal mortality, contributing to approximately 9% of maternal deaths globally. Among cardiovascular diseases complicating pregnancy, CHD is the most prevalent subtype. Here we conducted a comprehensive literature review on maternal and foetal outcomes associated with adult CHD-related pulmonary hypertension, also incorporating data from four pulmonary hypertension centres in Indonesia. Consistent with global epidemiological trends, atrial septal defect emerged as the most frequently observed form of CHD, followed by ventricular septal defect, across the four Indonesian centres. Maternal cardiovascular complications in this context include heart failure, arrhythmias, pulmonary hypertensive crises, thromboembolic events and aortic dissection. These haemodynamic disturbances further elevate the risk of adverse foetal outcomes, such as prematurity, low birth weight, intrauterine growth restriction and foetal demise. Effective and timely management of CHD and pulmonary hypertension – centred on optimising right ventricular function during pregnancy – is critical. Implementation of a comprehensive, multidisciplinary care approach, alongside the expansion of screening programmes for CHD in pregnant populations, is essential to improve maternal and foetal outcomes.
- Open Access
- 4 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluating the Clinical Accuracy of Wearable HRV Devices in Inflammation Monitoring: A Systematic Review (Preprint)
BACKGROUND Systemic inflammation is a key contributor to many chronic and acute diseases, yet its monitoring often requires invasive procedures. Heart rate variability (HRV), a non-invasive marker of autonomic nervous system function, has shown potential as a surrogate indicator of inflammation. With wearable devices now capable of continuous HRV monitoring, their clinical validity for inflammation detection requires systematic evaluation. OBJECTIVE This systematic review aims to evaluate the clinical accuracy of wearable devices in monitoring systemic inflammation by examining the association between heart rate variability (HRV) indices specifically SDNN and RMSSD and inflammatory biomarkers such as C-reactive protein (CRP), interleukins, and TNF-α across diverse inflammatory conditions. The goal is to assess the consistency and direction of associations and to explore the potential of wearable HRV monitoring as a non-invasive tool for inflammation detection. METHODS A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted (April 2025). Studies were eligible if they compared wearable-derived HRV parameters to inflammatory biomarkers (CRP, IL-6, IL-10, TNF-α). Risk of bias was assessed using QUADAS-2. Synthesis followed the SWiM guideline, employing vote counting and effect direction plots. RESULTS Eleven studies (n = 2,419) were included. Most studies found an inverse association between SDNN and CRP (83%; p = 0.031), while associations with cytokines (IL-6, IL-10, TNF-α) were inconsistent. RMSSD showed mixed results. Device type, recording duration, and population characteristics contributed to heterogeneity. CONCLUSIONS Wearable-derived HRV, especially SDNN, shows promise as a non-invasive marker of systemic inflammation, particularly for CRP. However, further research is needed to establish clinical utility and standardize measurement protocols. CLINICALTRIAL PROSPERO registration number CRD420251029821
- 4 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluating the Clinical Accuracy of Wearable HRV Devices in Inflammation Monitoring: A Systematic Review (Preprint)
BACKGROUND Systemic inflammation is a key contributor to many chronic and acute diseases, yet its monitoring often requires invasive procedures. Heart rate variability (HRV), a non-invasive marker of autonomic nervous system function, has shown potential as a surrogate indicator of inflammation. With wearable devices now capable of continuous HRV monitoring, their clinical validity for inflammation detection requires systematic evaluation. OBJECTIVE This systematic review aims to evaluate the clinical accuracy of wearable devices in monitoring systemic inflammation by examining the association between heart rate variability (HRV) indices specifically SDNN and RMSSD and inflammatory biomarkers such as C-reactive protein (CRP), interleukins, and TNF-α across diverse inflammatory conditions. The goal is to assess the consistency and direction of associations and to explore the potential of wearable HRV monitoring as a non-invasive tool for inflammation detection. METHODS A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted (April 2025). Studies were eligible if they compared wearable-derived HRV parameters to inflammatory biomarkers (CRP, IL-6, IL-10, TNF-α). Risk of bias was assessed using QUADAS-2. Synthesis followed the SWiM guideline, employing vote counting and effect direction plots. RESULTS Eleven studies (n = 2,419) were included. Most studies found an inverse association between SDNN and CRP (83%; p = 0.031), while associations with cytokines (IL-6, IL-10, TNF-α) were inconsistent. RMSSD showed mixed results. Device type, recording duration, and population characteristics contributed to heterogeneity. CONCLUSIONS Wearable-derived HRV, especially SDNN, shows promise as a non-invasive marker of systemic inflammation, particularly for CRP. However, further research is needed to establish clinical utility and standardize measurement protocols. CLINICALTRIAL PROSPERO registration number CRD420251029821
- Open Access
- 30 May 2025
- Published by Universitas Indonesia in Kesmas Jurnal Kesehatan Masyarakat Nasional (National Public Health Journal)
- Vol. 20 (2) , 147-156
Machine Learning for Preeclampsia Prediction: Enhancing Screening in Primary Health Care
Preeclampsia is a leading cause of maternal morbidity and mortality worldwide, with early detection being critical for reducing adverse outcomes. This study aimed to develop a machine learning model for predicting the risk of preeclampsia using readily available maternal characteristics such as body mass index, mean arterial pressure, and clinical history of hypertension or diabetes mellitus. Secondary data from 2,250 pregnancies were analyzed, addressing challenges such as missing data and class imbalance through preprocessing. Various algorithms, including support vector machines, random forest, and logistic regression, were evaluated. Herein, a support vector machines model with threshold adjustment showed the best performance, with a sensitivity of 67.5%, specificity of 57.23%, and an area under the curve of 0.68. These findings indicated the promising potential of scalable and interpretable prediction models for enhancing preeclampsia screening in primary health care settings. However, further refinement and validation of the proposed model are required for broader clinical integration to improve maternal and neonatal health outcomes.
- 30 May 2025
- Published by Universitas Indonesia in Kesmas Jurnal Kesehatan Masyarakat Nasional (National Public Health Journal)
- Vol. 20 (2) , 147-156
Open AccessMachine Learning for Preeclampsia Prediction: Enhancing Screening in Primary Health Care
Preeclampsia is a leading cause of maternal morbidity and mortality worldwide, with early detection being critical for reducing adverse outcomes. This study aimed to develop a machine learning model for predicting the risk of preeclampsia using readily available maternal characteristics such as body mass index, mean arterial pressure, and clinical history of hypertension or diabetes mellitus. Secondary data from 2,250 pregnancies were analyzed, addressing challenges such as missing data and class imbalance through preprocessing. Various algorithms, including support vector machines, random forest, and logistic regression, were evaluated. Herein, a support vector machines model with threshold adjustment showed the best performance, with a sensitivity of 67.5%, specificity of 57.23%, and an area under the curve of 0.68. These findings indicated the promising potential of scalable and interpretable prediction models for enhancing preeclampsia screening in primary health care settings. However, further refinement and validation of the proposed model are required for broader clinical integration to improve maternal and neonatal health outcomes.
- Open Access
- 4 February 2025
- Published by Indonesian Society of Obstetrics and Gynecology in Indonesian Journal of Obstetrics and Gynecology
- p. 23-30
Comparison of Pulsatility Index and Notching of Uterine Artery Doppler on Normotensive Pregnancy and Established Pre-eclampsia
Objective: The aim was to assess pulsatility index of uterine artery (Ut-A PI) of normotensive pregnancy and preeclampsia between 28-40 weeks of gestation. Methods: This cross-sectional study was conducted at Dr. Sardjito Hospital and Harapan Kita Maternal Children Hospital as a tertiary referral hospital. The study included 220 women high risk pregnancies. Result: There were 188 pregnant women normotensive pregnancy (85.5%) and 32 preeclampsia cases (14.5%). Weight, Body Mass Index, blood pressure, Mean Arterial Pressure, chronic hypertension, history of preeclampsia, and baby weight showed an significant association with preeclampsia. Pulsatility index of uterine artery had a sensitivity of 87.50% and a specificity of 98.94% whereas the notching had a sensitivity of 46.88% and a specificity of 87.23%. Conclusion: The UtA PI is a complementary tool with good performance for the diagnosis of overall and severe preeclampsia with high sensitivity and specificity. UtA PI has better performance the notching. Keywords: Pulsatility index, notching, normotensive, preeclampsia
- 4 February 2025
- Published by Indonesian Society of Obstetrics and Gynecology in Indonesian Journal of Obstetrics and Gynecology
- p. 23-30
Open AccessComparison of Pulsatility Index and Notching of Uterine Artery Doppler on Normotensive Pregnancy and Established Pre-eclampsia
Objective: The aim was to assess pulsatility index of uterine artery (Ut-A PI) of normotensive pregnancy and preeclampsia between 28-40 weeks of gestation. Methods: This cross-sectional study was conducted at Dr. Sardjito Hospital and Harapan Kita Maternal Children Hospital as a tertiary referral hospital. The study included 220 women high risk pregnancies. Result: There were 188 pregnant women normotensive pregnancy (85.5%) and 32 preeclampsia cases (14.5%). Weight, Body Mass Index, blood pressure, Mean Arterial Pressure, chronic hypertension, history of preeclampsia, and baby weight showed an significant association with preeclampsia. Pulsatility index of uterine artery had a sensitivity of 87.50% and a specificity of 98.94% whereas the notching had a sensitivity of 46.88% and a specificity of 87.23%. Conclusion: The UtA PI is a complementary tool with good performance for the diagnosis of overall and severe preeclampsia with high sensitivity and specificity. UtA PI has better performance the notching. Keywords: Pulsatility index, notching, normotensive, preeclampsia
- Open Access
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e033617
Multi‐Organ Phenotypes of Offspring Born Following Hypertensive Disorders of Pregnancy: A Systematic Review
Background: Hypertensive pregnancies are associated with an increased risk of cardiovascular and neurological diseases in the offspring during later life. However, less is known about the potential impact on multi‐organ phenotypes in offspring before disease symptoms occur. The objective of this systematic review was to determine the associations of fetal exposure to maternal hypertensive pregnancy with multi‐organ phenotypes across developmental stages. Methods and Results: Ovid MEDLINE, EMBASE, CENTRAL (Cochrane Central Register of Controlled Trials), WoS, Scopus, CINAHL, and ClinicalTrials.gov were systematically searched until February 2024. Records were independently screened by 2 authors. Studies reporting on the structure or function of the heart, blood vessels, brain, liver, and kidneys in offspring of hypertensive pregnancies compared with a normotensive control population were included. Risk of bias was assessed using the Newcastle‐Ottawa Scale. Extracted data were presented using harvest plots. Seventy‐three studies including 7091 offspring of hypertensive pregnancies and 42 164 controls were identified that met the inclusion criteria. Thirty‐two studies were investigations in fetuses, 24 in neonates and infants, 12 in children, 2 in adolescents, and 3 in adults. Offspring of hypertensive pregnancies had structural and functional changes in the heart compared with controls in some studies across developmental stages. Offspring of hypertensive pregnancies also had smaller occipital and parietal vessels, higher aortic intima‐media thickness, and lower retinal arteriolar‐to‐venular ratio. Some conflicting evidence existed for other phenotypical alterations. Conclusions: There is still inconsistent evidence of multi‐organ structural and functional differences in offspring of hypertensive pregnancies. The evidence base could therefore be further strengthened through well‐designed and conducted prospective studies. Registration Information: www.crd.york.ac.uk . Unique Identifier: CRD42023387550.
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e033617
Open AccessMulti‐Organ Phenotypes of Offspring Born Following Hypertensive Disorders of Pregnancy: A Systematic Review
Background: Hypertensive pregnancies are associated with an increased risk of cardiovascular and neurological diseases in the offspring during later life. However, less is known about the potential impact on multi‐organ phenotypes in offspring before disease symptoms occur. The objective of this systematic review was to determine the associations of fetal exposure to maternal hypertensive pregnancy with multi‐organ phenotypes across developmental stages. Methods and Results: Ovid MEDLINE, EMBASE, CENTRAL (Cochrane Central Register of Controlled Trials), WoS, Scopus, CINAHL, and ClinicalTrials.gov were systematically searched until February 2024. Records were independently screened by 2 authors. Studies reporting on the structure or function of the heart, blood vessels, brain, liver, and kidneys in offspring of hypertensive pregnancies compared with a normotensive control population were included. Risk of bias was assessed using the Newcastle‐Ottawa Scale. Extracted data were presented using harvest plots. Seventy‐three studies including 7091 offspring of hypertensive pregnancies and 42 164 controls were identified that met the inclusion criteria. Thirty‐two studies were investigations in fetuses, 24 in neonates and infants, 12 in children, 2 in adolescents, and 3 in adults. Offspring of hypertensive pregnancies had structural and functional changes in the heart compared with controls in some studies across developmental stages. Offspring of hypertensive pregnancies also had smaller occipital and parietal vessels, higher aortic intima‐media thickness, and lower retinal arteriolar‐to‐venular ratio. Some conflicting evidence existed for other phenotypical alterations. Conclusions: There is still inconsistent evidence of multi‐organ structural and functional differences in offspring of hypertensive pregnancies. The evidence base could therefore be further strengthened through well‐designed and conducted prospective studies. Registration Information: www.crd.york.ac.uk . Unique Identifier: CRD42023387550.
- Top Cited PapersOpen Access
- 30 July 2024
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 24 (1) , 1-14
Trends and causes of maternal mortality in Indonesia: a systematic review
Background: The maternal mortality ratio (MMR) in Indonesia is among the highest in Southeast Asia. We aim to describe trends in the MMR and causes of maternal deaths in Indonesia over the past decades, regionally and nationally. Methods: We performed a systematic review and conducted a search using PubMed, Embase, Global Health, CINAHL, Cochrane, Portal Garuda, and Google Scholar from the inception of the database to April 2023. We included all studies on the incidence and/or the causes of maternal deaths in Indonesia. The MMR was defined as the number of maternal deaths per 100,000 live births. Maternal death causes were assessed and reclassified according to the WHO International Classification of Disease Maternal Mortality (ICD-MM). Results: We included 63 studies that reported the MMR (54 studies) and/or the causes of maternal deaths (44 studies) in Indonesia from 1970 to 2022, with a total of 254,796 maternal deaths. The national MMR declined from 450 to 249 (45%) between 1990 and 2020. Great differences in MMR exist across the country, with the lowest in Java-Bali and the highest (more than twice the national MMR) in Sulawesi and Eastern Indonesia. Between 1990 and 2022, the proportion of deaths due to hemorrhage and sepsis decreased, respectively from 48 to 18% and 15–5%, while the share of deaths due to hypertensive disorders and non-obstetric causes increased, respectively from 8 to 19% and 10–49%. Conclusion: Despite the steady decline of maternal deaths in Indonesia, it remains one of the highest in Southeast Asia, with enormous disparities within the country. Hypertensive disorders and non-communicable diseases make up a growing share of maternal deaths, making maternal death reduction strategies increasingly challenging. National Maternal Death Surveillance and Response needs to be prioritized to eliminate preventable maternal deaths in Indonesia. Registration of systematic reviews: PROSPERO, CRD42022320213.
- 30 July 2024
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 24 (1) , 1-14
Top Cited PapersOpen AccessTrends and causes of maternal mortality in Indonesia: a systematic review
Background: The maternal mortality ratio (MMR) in Indonesia is among the highest in Southeast Asia. We aim to describe trends in the MMR and causes of maternal deaths in Indonesia over the past decades, regionally and nationally. Methods: We performed a systematic review and conducted a search using PubMed, Embase, Global Health, CINAHL, Cochrane, Portal Garuda, and Google Scholar from the inception of the database to April 2023. We included all studies on the incidence and/or the causes of maternal deaths in Indonesia. The MMR was defined as the number of maternal deaths per 100,000 live births. Maternal death causes were assessed and reclassified according to the WHO International Classification of Disease Maternal Mortality (ICD-MM). Results: We included 63 studies that reported the MMR (54 studies) and/or the causes of maternal deaths (44 studies) in Indonesia from 1970 to 2022, with a total of 254,796 maternal deaths. The national MMR declined from 450 to 249 (45%) between 1990 and 2020. Great differences in MMR exist across the country, with the lowest in Java-Bali and the highest (more than twice the national MMR) in Sulawesi and Eastern Indonesia. Between 1990 and 2022, the proportion of deaths due to hemorrhage and sepsis decreased, respectively from 48 to 18% and 15–5%, while the share of deaths due to hypertensive disorders and non-obstetric causes increased, respectively from 8 to 19% and 10–49%. Conclusion: Despite the steady decline of maternal deaths in Indonesia, it remains one of the highest in Southeast Asia, with enormous disparities within the country. Hypertensive disorders and non-communicable diseases make up a growing share of maternal deaths, making maternal death reduction strategies increasingly challenging. National Maternal Death Surveillance and Response needs to be prioritized to eliminate preventable maternal deaths in Indonesia. Registration of systematic reviews: PROSPERO, CRD42022320213.
- Open Access
Preconception Maternal Mentoring for Improved Fetal Growth among Indonesian Women: Results from a Cluster Randomized Controlled Trial
The prevalence of stunting in young children is associated with poor growth during the prenatal and early postnatal periods. A maternal mentoring program was developed for Indonesian women to improve birth outcomes. A cluster-randomized controlled trial (CRCT) was conducted in three sub-districts of the Special Region of Yogyakarta, Indonesia. A total of 384 eligible participants were randomly allocated to either an intervention (received the maternal mentoring program and standard care; n = 189) or control (received standard care only; n = 195) group. The maternal mentoring program provided preconception health education; health monitoring; and text message reminders for preconception women. Fetal growth was measured between gestational weeks 27 and 30 using the estimated fetal weight generated from ultrasonographic measurements. Birth weight was measured within 24 h of birth. A structured questionnaire captured women’s demographics, pregnancy readiness, and body mass indexes (BMIs). After adjustment, fetal weight was 14% (95% CI: 5.1–23.0) higher in the intervention group than in the control group, and the average weight-for-length Z-score at birth was 0.16 (95% CI: 0.04–0.30) higher in the intervention group than in the control group. The maternal mentoring program was associated with improved fetal growth and birth weight in this population and should be considered for scale-up to other settings, nationally and globally.
Open AccessPreconception Maternal Mentoring for Improved Fetal Growth among Indonesian Women: Results from a Cluster Randomized Controlled Trial
The prevalence of stunting in young children is associated with poor growth during the prenatal and early postnatal periods. A maternal mentoring program was developed for Indonesian women to improve birth outcomes. A cluster-randomized controlled trial (CRCT) was conducted in three sub-districts of the Special Region of Yogyakarta, Indonesia. A total of 384 eligible participants were randomly allocated to either an intervention (received the maternal mentoring program and standard care; n = 189) or control (received standard care only; n = 195) group. The maternal mentoring program provided preconception health education; health monitoring; and text message reminders for preconception women. Fetal growth was measured between gestational weeks 27 and 30 using the estimated fetal weight generated from ultrasonographic measurements. Birth weight was measured within 24 h of birth. A structured questionnaire captured women’s demographics, pregnancy readiness, and body mass indexes (BMIs). After adjustment, fetal weight was 14% (95% CI: 5.1–23.0) higher in the intervention group than in the control group, and the average weight-for-length Z-score at birth was 0.16 (95% CI: 0.04–0.30) higher in the intervention group than in the control group. The maternal mentoring program was associated with improved fetal growth and birth weight in this population and should be considered for scale-up to other settings, nationally and globally.